This activity is expired and is no longer available for CME credit.


Best of RA Forum™ 2016

Author(s)/Faculty: Leonard H. Calabrese, DO; Joseph E. Craft, MD; William F.C. Rigby, MD
Release Date: 9/9/2016Expiration Date: 9/8/2018
Credit Type: CMENumber of Credits: 0
Content Type: LectureProvider:
Rheumatoid arthritis (RA) is a progressive and painful systemic inflammatory disease that preferentially attacks the synovium of the joint leading to joint destruction, debility, and deformity. Increased understanding of the underlying pathophysiology of RA has made a remarkable difference in its treatment and prognosis. Numerous therapeutic agents with diverse targets and mechanisms have been added to the RA armamentarium, allowing for intervention at various stages in the pathogenic process of the disease. By understanding the underlying immunologic mechanisms driving RA progression, clinicians involved in the management of patients with RA will be better equipped to evaluate the clinical and pharmacologic safety, as well as efficacy profiles of current and emerging therapies. In this activity, leading rheumatologists will integrate discussions of basic immunologic principles with current and emerging RA treatments. Mechanisms of autoimmunity and inflammation will be compared to the emerging role of checkpoint therapy in novel treatment approaches.